Login / Signup
Sintilimab plus GemOx is an effective salvage therapy in patients with refractory/relapsing nodal peripheral T cell lymphomas.
Xibin Xiao
Mengmeng Hu
Huawei Jiang
Panpan Chen
Huyi Lei
Published in:
Journal of cancer research and clinical oncology (2024)
Sintilimab plus GemOx showed encouraging activity and manageable toxicity for patients with r/r PTCL.
Keyphrases
</>
multiple sclerosis
oxidative stress
lymph node
neoadjuvant chemotherapy
disease activity
stem cells
chemotherapy induced
squamous cell carcinoma
systemic lupus erythematosus
rheumatoid arthritis
bone marrow
oxide nanoparticles
rectal cancer